Clinical Trial Update: A Clinical Study of AK101 in Subjects With Moderate to Severe Plaque Psoriasis [Phase 1, Phase 2]

View source ↗

Summary

The AK101 study in moderate to severe plaque psoriasis has completed Phase 1 and Phase 2.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plaque Psoriasis

Drugs mentioned

• AK101

Snippet

Sponsor: Akeso | Conditions: Plaque Psoriasis | Phase 1, Phase 2 | Status: COMPLETED